Linda G. Hughes, MA

Study results indicate that treatment with alemtuzumab reduces focal inflammation, with durable effects that may be due to the distinct pattern of lymphocyte depletion and repopulation after treatment.

A presentation at the 2015 CMSC annual meeting made the case that focal, specific, subacute, neurologic problems in otherwise healthy adults should be diligently followed, and MRI can be an useful tool in differential diagnosis.

Addiction is a chronic and progressive brain disease of the reward, motivation, and memory pathway that moves from an impulse or positive reinforcement to compulsive and negative reinforcement.

Treatment failure can be caused by a variety of factors, including misdiagnosis of the primary psychiatric complaint, the presence of one or more comorbid conditions, and nonadherence to medication plans.

A pattern of sleep disturbance is a risk factor for depression and suicide and also increases the risk of cancer, infection, hypertension, weight gain, heart disease, diabetes, inflammation, osteoporosis, chronic pain, and arrhythmias. It can also have a significant negative impact on cognition and creativity.

How can clinicians help veterans with PTSD deal with depression and anxiety symptoms, and process intense feelings of shame and guilt stemming from actions and situations they experienced while serving?